NO20090811L - Fremgangsmate for fremstilling av 3(R)-(2-hydroksy-2,2-ditien-2-ylacetoksy)-1-(3-fenoksypropyl)-1-azoniabicyklo[2.2.2]oktanbromid - Google Patents

Fremgangsmate for fremstilling av 3(R)-(2-hydroksy-2,2-ditien-2-ylacetoksy)-1-(3-fenoksypropyl)-1-azoniabicyklo[2.2.2]oktanbromid

Info

Publication number
NO20090811L
NO20090811L NO20090811A NO20090811A NO20090811L NO 20090811 L NO20090811 L NO 20090811L NO 20090811 A NO20090811 A NO 20090811A NO 20090811 A NO20090811 A NO 20090811A NO 20090811 L NO20090811 L NO 20090811L
Authority
NO
Norway
Prior art keywords
dithien
hydroxy
phenoxypropyl
ylacetoxy
azoniabicyclo
Prior art date
Application number
NO20090811A
Other languages
English (en)
Norwegian (no)
Inventor
Nuria Busquets Baque
Francesca Pajuelo Lorenzo
Original Assignee
Almirall Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=37808353&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20090811(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Almirall Lab filed Critical Almirall Lab
Publication of NO20090811L publication Critical patent/NO20090811L/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D453/00Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • C07D453/02Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
NO20090811A 2006-07-21 2009-02-20 Fremgangsmate for fremstilling av 3(R)-(2-hydroksy-2,2-ditien-2-ylacetoksy)-1-(3-fenoksypropyl)-1-azoniabicyklo[2.2.2]oktanbromid NO20090811L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ES200601951A ES2298049B1 (es) 2006-07-21 2006-07-21 Procedimiento para fabricar bromuro de 3(r)-(2-hidroxi-2,2-ditien-2-ilacetoxi)-1-(3-fenoxipropil)-1-azoniabiciclo (2.2.2) octano.
PCT/EP2007/006278 WO2008009397A1 (en) 2006-07-21 2007-07-16 Process for manufacturing 3(r)-(2-hydroxy-2,2-dithien-2-ylacetoxy)-1-(3-phenoxypropyl)-1-azoniabicyclo[2.2.2]octane bromide

Publications (1)

Publication Number Publication Date
NO20090811L true NO20090811L (no) 2009-02-20

Family

ID=37808353

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20090811A NO20090811L (no) 2006-07-21 2009-02-20 Fremgangsmate for fremstilling av 3(R)-(2-hydroksy-2,2-ditien-2-ylacetoksy)-1-(3-fenoksypropyl)-1-azoniabicyklo[2.2.2]oktanbromid

Country Status (37)

Country Link
US (1) US8044205B2 (uk)
EP (1) EP2044067B1 (uk)
JP (1) JP5279708B2 (uk)
KR (1) KR101410198B1 (uk)
CN (1) CN101490048B (uk)
AR (1) AR061933A1 (uk)
AT (1) ATE449096T1 (uk)
AU (1) AU2007276395B2 (uk)
BR (1) BRPI0711500B1 (uk)
CA (1) CA2657679C (uk)
CL (1) CL2007002078A1 (uk)
CO (1) CO6460740A2 (uk)
CY (1) CY1109792T1 (uk)
DE (1) DE602007003375D1 (uk)
DK (1) DK2044067T3 (uk)
EC (1) ECSP099033A (uk)
EG (1) EG25727A (uk)
ES (2) ES2298049B1 (uk)
HK (1) HK1124051A1 (uk)
HR (1) HRP20090652T1 (uk)
IL (1) IL196324A (uk)
ME (1) ME01773B (uk)
MX (1) MX2009000573A (uk)
MY (1) MY145285A (uk)
NO (1) NO20090811L (uk)
NZ (1) NZ573170A (uk)
PE (1) PE20081307A1 (uk)
PL (1) PL2044067T3 (uk)
PT (1) PT2044067E (uk)
RS (1) RS51264B (uk)
RU (1) RU2439070C2 (uk)
SI (1) SI2044067T1 (uk)
TW (1) TWI363057B (uk)
UA (1) UA96453C2 (uk)
UY (1) UY30475A1 (uk)
WO (1) WO2008009397A1 (uk)
ZA (1) ZA200810051B (uk)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2165768B1 (es) 1999-07-14 2003-04-01 Almirall Prodesfarma Sa Nuevos derivados de quinuclidina y composiciones farmaceuticas que los contienen.
CA2608561A1 (en) * 2007-10-29 2009-04-29 Carl Paluszkiewicz Motorcycle wind deflector accessory support
EP2100599A1 (en) 2008-03-13 2009-09-16 Laboratorios Almirall, S.A. Inhalation composition containing aclidinium for treatment of asthma and chronic obstructive pulmonary disease
EP2100598A1 (en) * 2008-03-13 2009-09-16 Laboratorios Almirall, S.A. Inhalation composition containing aclidinium for treatment of asthma and chronic obstructive pulmonary disease
EP2510928A1 (en) 2011-04-15 2012-10-17 Almirall, S.A. Aclidinium for use in improving the quality of sleep in respiratory patients
EP2666465A1 (en) 2012-05-25 2013-11-27 Almirall, S.A. Novel dosage and formulation
CZ306791B6 (cs) * 2013-10-29 2017-07-12 Zentiva, K.S. Průmyslově využitelný způsob přípravy aklidinium bromidu o vysoké čistotě
CN103755699A (zh) * 2014-01-06 2014-04-30 万特制药(海南)有限公司 一种2-羟基-2,2-二噻吩-2-基乙酸-1-氮杂二环[2,2,2]辛-3(r)-基酯制备方法
CN103755698A (zh) * 2014-01-06 2014-04-30 万特制药(海南)有限公司 一锅法制备阿地溴铵的工艺
CZ2014188A3 (cs) 2014-03-26 2015-10-07 Zentiva, K.S. Nové formy aclidinium chloridu a způsob jejich přípravy
CN104478871B (zh) * 2014-12-26 2016-09-07 东华大学 一种胆碱m受体拮抗剂阿地溴铵及其制备方法
PT108370B (pt) * 2015-03-30 2018-10-25 Hovione Farm S A Processo de preparação de brometo de aclidínio
WO2016162878A1 (en) * 2015-04-04 2016-10-13 Harman Finochem Limited An advantageous process for preparing 1-azoniabicyclo[2.2.2]octane,3-[(hydroxydi-2-thienylacetyl)oxy]-1-(3¬phenoxypropyl)-, bromide, (3r)- and its novel crystalline form-i
CZ2015257A3 (cs) 2015-04-16 2016-10-26 Zentiva, K.S. Způsob pro zmenšování velikosti částic bromidu [(3R)-1-(3-fenoxypropyl)chinuklidin-1-ium-3-yl] 2-hydroxy-2,2-bis(2-thienyl)acetátu

Family Cites Families (65)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1219606A (en) 1968-07-15 1971-01-20 Rech S Et D Applic Scient Soge Quinuclidinol derivatives and preparation thereof
FR2414044A1 (fr) 1978-01-10 1979-08-03 Pharmindustrie Nouveaux derives d'aza-1 bicyclo(2,2,2) octane, utilisables comme medicaments
FR2539135B1 (fr) 1983-01-11 1986-02-28 Essilor Int Hydrogels de polyurethane et procede de fabrication
GB8334494D0 (en) 1983-12-24 1984-02-01 Tanabe Seiyaku Co Carbostyril derivatives
US4675326A (en) 1985-05-08 1987-06-23 Gabriel Amitai Bisquaternary antidotes
US4843074A (en) 1988-05-17 1989-06-27 Marion Laboratories, Inc. 1-azabicyclo[2.2.2]octan-3-yl 2-aryl-3-azacyclo-2-hydroxypropionates and their quaternary salts
US5610163A (en) 1989-09-16 1997-03-11 Boehringer Ingelheim Gmbh Esters of thienyl carboxylic acids and amino alcohols and their quaternization products
DE3931041C2 (de) 1989-09-16 2000-04-06 Boehringer Ingelheim Kg Ester von Thienylcarbonsäuren mit Aminoalkoholen, ihre Quaternierungsprodukte, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel
GB8923590D0 (en) 1989-10-19 1989-12-06 Pfizer Ltd Antimuscarinic bronchodilators
US5201308A (en) 1990-02-14 1993-04-13 Newhouse Michael T Powder inhaler
US5091528A (en) 1990-09-12 1992-02-25 Allergan, Inc. 6- or 7- (2-imino-2-imidazolidine)-1,4-benzoxazines as α adrenergic agents
DE4108393A1 (de) 1991-03-15 1992-09-17 Boehringer Ingelheim Kg Neue ester bi- und tricyclischer aminoalkohole, ihre herstellung und ihre verwendung in arzneimitteln
DE4239402A1 (de) 1992-11-24 1994-05-26 Bayer Ag Pulverinhalator
WO1995021820A1 (fr) 1994-02-10 1995-08-17 Yamanouchi Pharmaceutical Co., Ltd. Nouveau derive du carbamate et composition correspondante
NO2005012I1 (no) * 1994-12-28 2005-06-06 Debio Rech Pharma Sa Triptorelin og farmasoytisk akseptable salter derav
ATE297773T1 (de) 1995-04-14 2005-07-15 Smithkline Beecham Corp Dosierinhalator für salmeterol
FR2756739B1 (fr) 1996-12-05 2000-04-28 Astra Ab Nouvelle formulation de budesonide
TR200003721T2 (tr) 1998-06-18 2001-06-21 Boehringer Ingelheim Pharmaceuticals, Inc. Spreyler için farmasötik formülasyonlar
NZ509489A (en) 1998-08-04 2002-10-25 Jago Res A Medicinal aerosol formulations comprising cromoglycic acid and/or nedocromil
GB9902689D0 (en) 1999-02-08 1999-03-31 Novartis Ag Organic compounds
DE19921693A1 (de) 1999-05-12 2000-11-16 Boehringer Ingelheim Pharma Neuartige Arzneimittelkompositionen auf der Basis von anticholinergisch wirksamen Verbindungen und ß-Mimetika
ES2165768B1 (es) 1999-07-14 2003-04-01 Almirall Prodesfarma Sa Nuevos derivados de quinuclidina y composiciones farmaceuticas que los contienen.
US7214687B2 (en) 1999-07-14 2007-05-08 Almirall Ag Quinuclidine derivatives and medicinal compositions containing the same
FR2803378B1 (fr) 1999-12-29 2004-03-19 Valeo Climatisation Echangeur de chaleur a tubes a plusieurs canaux, en particulier pour vehicule automobile
GB0009605D0 (en) 2000-04-18 2000-06-07 Glaxo Group Ltd Medicaments
GB0009583D0 (en) 2000-04-18 2000-06-07 Glaxo Group Ltd Respiratory formulations
GB0009592D0 (en) 2000-04-18 2000-06-07 Glaxo Group Ltd Respiratory combinations
GB0009606D0 (en) 2000-04-18 2000-06-07 Glaxo Group Ltd Therapeutic combinations
US20020151541A1 (en) 2000-10-31 2002-10-17 Michel Pairet Pharmaceutical compositions containing tiotropium salts and antihistamines and their use
US20020193393A1 (en) 2001-03-07 2002-12-19 Michel Pairet Pharmaceutical compositions based on anticholinergics and PDE-IV inhibitors
US20020183292A1 (en) 2000-10-31 2002-12-05 Michel Pairet Pharmaceutical compositions based on anticholinergics and corticosteroids
US7776315B2 (en) 2000-10-31 2010-08-17 Boehringer Ingelheim Pharma Gmbh & Co. Kg Pharmaceutical compositions based on anticholinergics and additional active ingredients
DE10062712A1 (de) 2000-12-15 2002-06-20 Boehringer Ingelheim Pharma Neue Arzneimittelkompositionen auf der Basis von Anticholinergika und Corticosteroiden
US20030158196A1 (en) 2002-02-16 2003-08-21 Boehringer Ingelheim Pharma Gmbh Co. Kg Pharmaceutical compositions based on anticholinergics and EGFR kinase inhibitors
US20020137764A1 (en) 2000-10-31 2002-09-26 Karin Drechsel Inhalable formulation of a solution containing a tiotropium salt
US6620438B2 (en) 2001-03-08 2003-09-16 Boehringer Ingelheim Pharma Kg Pharmaceutical compositions based on anticholinergics and NK1-receptor antagonists
US6608054B2 (en) 2001-03-20 2003-08-19 Boehringer Ingelheim Pharma Kg Pharmaceutical compositions based on anticholinergics and endothelin antagonists
US20020122773A1 (en) 2000-12-20 2002-09-05 Michel Pairet Pharmaceutical compositions based on anticholinergics and dopamine agonists
JP2004512359A (ja) 2000-10-31 2004-04-22 ベーリンガー インゲルハイム ファルマ ゲゼルシャフト ミット ベシュレンクテル ハフツング ウント コンパニー コマンディトゲゼルシャフト 抗コリン作用薬及びコルチコステロイドをベースとする新規医薬組成物
US20020193392A1 (en) 2000-11-13 2002-12-19 Christel Schmelzer Pharmaceutical compositions based on tiotropium salts of salts of salmeterol
DE10056104A1 (de) 2000-11-13 2002-05-23 Boehringer Ingelheim Pharma Neue Arzneimittelkompositionen auf der Basis von Tiotropiumsalzen und Salzen des Salmeterols
US20100310477A1 (en) 2000-11-28 2010-12-09 Boehringer Ingelheim Pharma Gmbh & Co. Kg. Pharmaceutical compositions based on anticholingerics and additional active ingredients
WO2002051841A1 (en) 2000-12-22 2002-07-04 Almirall Prodesfarma Ag Quinuclidine carbamate derivatives and their use as m3 antagonists
RU2282629C2 (ru) 2000-12-28 2006-08-27 Альмиралль Продесфарма Аг Производные хинуклидина, способ их получения и фармацевтическая композиция на их основе
DE10104367A1 (de) 2001-02-01 2002-08-08 Boehringer Ingelheim Pharma Betamimetika enthaltende Arzneimittelkompositionen mit geringeren Nebenwirkungen
US20020179087A1 (en) 2001-02-01 2002-12-05 Karl-Heinz Bozung Pharmaceutical compositions containing an oxitropium salt and a betamimetic
US20020189610A1 (en) 2001-02-01 2002-12-19 Karl-Heinz Bozung Pharmaceutical compositions containing an ipratropium salt and a betamimetic
DE10104370A1 (de) 2001-02-01 2002-08-08 Boehringer Ingelheim Pharma Arzneimittelkompositionen mit geringeren Nebenwirkungen
US20030018019A1 (en) 2001-06-23 2003-01-23 Boehringer Ingelheim Pharma Kg Pharmaceutical compositions based on anticholinergics, corticosteroids and betamimetics
DE10130371A1 (de) 2001-06-23 2003-01-02 Boehringer Ingelheim Pharma Neue Arzneimittelkompositionen auf der Basis von Anticholinergika, Corticosteroiden und Betamimetika
ES2206021B1 (es) * 2002-04-16 2005-08-01 Almirall Prodesfarma, S.A. Nuevos derivados de pirrolidinio.
ES2195785B1 (es) 2002-05-16 2005-03-16 Almirall Prodesfarma, S.A. Nuevos derivados de piridazin-3(2h)-ona.
ES2204295B1 (es) * 2002-07-02 2005-08-01 Almirall Prodesfarma, S.A. Nuevos derivados de quinuclidina-amida.
ES2211315B1 (es) 2002-11-12 2005-10-16 Almirall Prodesfarma, S.A. Nuevos compuestos triciclicos.
ES2211344B1 (es) 2002-12-26 2005-10-01 Almirall Prodesfarma, S.A. Nuevos derivados de piridazin-3(2h)-ona.
US20050026887A1 (en) 2003-07-29 2005-02-03 Boehringer Ingelheim International Gmbh Medicaments for inhalation comprising an anticholinergic and a steroid
CA2534128C (en) 2003-07-29 2012-10-23 Boehringer Ingelheim International Gmbh Combination of an anticholinergic and a steroid and its use to treat respiratory disorders by inhalation
US20050026886A1 (en) 2003-07-29 2005-02-03 Boehringer Ingelheim International Gmbh Medicaments for inhalation comprising an anticholinergic and a PDE IV inhibitor
US20050026948A1 (en) 2003-07-29 2005-02-03 Boehringer Ingelheim International Gmbh Medicaments for inhalation comprising an anticholinergic and a betamimetic
US20050025718A1 (en) 2003-07-31 2005-02-03 Boehringer Ingelheim International Gmbh Medicaments for inhalation comprising an anticholinergic and a betamimetic
ES2232306B1 (es) 2003-11-10 2006-08-01 Almirall Prodesfarma, S.A. Nuevos derivados de piridazin-3(2h)-ona.
ES2239546B1 (es) 2004-03-15 2006-12-01 Almirall Prodesfarma, S.A. Nuevos esteres de quinuclidina cuaternizados.
ES2257152B1 (es) 2004-05-31 2007-07-01 Laboratorios Almirall S.A. Combinaciones que comprenden agentes antimuscarinicos y agonistas beta-adrenergicos.
EP2100598A1 (en) 2008-03-13 2009-09-16 Laboratorios Almirall, S.A. Inhalation composition containing aclidinium for treatment of asthma and chronic obstructive pulmonary disease
EP2100599A1 (en) 2008-03-13 2009-09-16 Laboratorios Almirall, S.A. Inhalation composition containing aclidinium for treatment of asthma and chronic obstructive pulmonary disease

Also Published As

Publication number Publication date
EP2044067B1 (en) 2009-11-18
SI2044067T1 (sl) 2010-03-31
CL2007002078A1 (es) 2008-01-25
KR20090031578A (ko) 2009-03-26
RU2439070C2 (ru) 2012-01-10
UY30475A1 (es) 2008-01-02
TW200821307A (en) 2008-05-16
PL2044067T3 (pl) 2010-04-30
CY1109792T1 (el) 2014-09-10
DE602007003375D1 (de) 2009-12-31
CN101490048B (zh) 2011-06-29
BRPI0711500B1 (pt) 2014-09-16
PE20081307A1 (es) 2008-09-17
AU2007276395B2 (en) 2012-03-08
HK1124051A1 (en) 2009-07-03
HRP20090652T1 (hr) 2010-01-31
ES2298049B1 (es) 2009-10-20
ES2336045T3 (es) 2010-04-07
WO2008009397A8 (en) 2009-01-22
EG25727A (en) 2012-06-11
EP2044067A1 (en) 2009-04-08
TWI363057B (en) 2012-05-01
ES2298049A1 (es) 2008-05-01
AR061933A1 (es) 2008-10-01
JP2009544591A (ja) 2009-12-17
UA96453C2 (uk) 2011-11-10
IL196324A (en) 2012-12-31
IL196324A0 (en) 2009-09-22
ATE449096T1 (de) 2009-12-15
ME01773B (me) 2010-12-31
JP5279708B2 (ja) 2013-09-04
RU2009105827A (ru) 2010-08-27
CA2657679C (en) 2014-10-21
US20090299042A1 (en) 2009-12-03
MX2009000573A (es) 2009-01-29
CO6460740A2 (es) 2012-06-15
BRPI0711500A2 (pt) 2011-11-01
KR101410198B1 (ko) 2014-06-19
CN101490048A (zh) 2009-07-22
WO2008009397A1 (en) 2008-01-24
AU2007276395A1 (en) 2008-01-24
US8044205B2 (en) 2011-10-25
ECSP099033A (es) 2009-02-27
MY145285A (en) 2012-01-13
PT2044067E (pt) 2009-12-21
ZA200810051B (en) 2009-11-25
CA2657679A1 (en) 2008-01-24
RS51264B (sr) 2010-12-31
NZ573170A (en) 2010-12-24
DK2044067T3 (da) 2010-02-01

Similar Documents

Publication Publication Date Title
NO20090811L (no) Fremgangsmate for fremstilling av 3(R)-(2-hydroksy-2,2-ditien-2-ylacetoksy)-1-(3-fenoksypropyl)-1-azoniabicyklo[2.2.2]oktanbromid
UA126304C2 (uk) Макроцикли як модулятори муковісцидозного трансмембранного регулятора провідності, їх фармацевтичні композиції, застосування їх для лікування муковісцидозу та спосіб їх виготовлення
Zhu et al. Total Synthesis and Structural Revision of (+)‐Uprolide G Acetate
NO20092960L (no) Krystallinsk minocycline base og framgangsmater for framstilling av denne
Bagal et al. Syntheses of the enantiomers of 1-deoxynojirimycin and 1-deoxyaltronojirimycin via chemo-and diastereoselective olefinic oxidation of unsaturated amines
NO20071901L (no) Substituerte bisykliske imidazo-3-ylamin sammensetninger
NO20091599L (no) Kjemiske forbindelser
WO2011071314A3 (en) Processes for preparing crystalline forms a and b of ilaprazole and process for converting the crystalline forms
MY138283A (en) Process for isolating vinyl acetate
WO2010030132A3 (ko) 아데포비어 디피복실의 정제방법
WO2008123233A1 (ja) 感放射線樹脂組成物、アクティブマトリックス基板及びその製造方法
Ying et al. Lycopodium alkaloids from Huperzia serrata
Kaźmierczak et al. Regioselective Fluorination of α‐Hydroxy‐β‐aminophosphonates by Using PyFluor
WO2007088558A3 (en) A process for purification of valsartan
CN107286092A (zh) 甲氧基苯甲酰胺和重氮酸酯经碳‑氢官能化制备异喹啉二酮的方法
Yu et al. A safe, convenient and efficient one-pot synthesis of α-chloroketone acetals directly from ketones using iodobenzene dichloride
Shabareesh et al. Structural and functional characterization of hirudin P6 derived novel bivalent thrombin inhibitors–Studying the effect of linker length and glycosylation on their function
Barluenga et al. [8+ 2] and [8+ 3] Cyclization Reactions of Alkenyl Carbenes and 8‐Azaheptafulvenes: Direct Access to Tetrahydro‐1‐azaazulene and Cyclohepta [b] pyridinone Derivatives
Kozioł et al. Ferrier− Petasis Rearrangement of 4-(Vinyloxy) azetidin-2-ones: An Entry to Carbapenams and Carbacephams
NO20074741L (no) Fremgangsmate for fremstilling av farmakokinetisk forbedrede forbindelser omfattende funksjonelle rester eller grupper, og farmasoytiske preparater omfattende angitte forbindelser
TH105535A (th) กระบวนการสำหรับการผลิต 3(r)-(2-ไฮดรอกซี-2,2-ไดธิอีน-2-อิลอะเซทอกซี)-1-(3-ฟีนอกซีโพรพิล)-1-อะโซเนียไบไซโคล[2.2.2]ออกเทน บรอมีด
HENSENS et al. STRUCTURE ELUCIDATION OF ANGIOTENSIN CONVERTING ENZYME INHIBITOR L-681, 176 FROM STREPTOMYCES SP. MA 5143a
Li et al. 18-Hydroxy-11-deoxycorticosterone. Chemical synthesis, structure, and circular dichroism
TH84651B (th) กระบวนการสำหรับการเตรียมคลอโรไฮดรินโดยการทำคลอริเนชันพอลิไฮดรอกซิเลเทคแอลิแฟติกไฮโดรคาร์บอน
TW200706535A (en) N-hydroxyl cyclic imide compound and preparation method thereof

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application